Table 4.
DRLci for chest CT
| Chest CT | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| References | Lung cancer | Interstitial lung disease (axial) | Interstitial lung disease (helical) | Pulmonary embolism | CCTA | Calcium scoring | ||||||
| ctdivol (mgy) | dlp (mgy.cm) | ctdivol (mgy) | dlp (mgy.cm) | ctdivol (mgy) | dlp (mgy.cm) | ctdivol (mgy) | dlp (mgy.cm) | ctdivol (mgy) | dlp (mgy.cm) | ctdivol (mgy) | dlp (mgy.cm) | |
| Castellano et al. (UK) 2017 [22] | – | – | – | – | – | – | – | – | – | 173 | – | – |
| Danish Health Authority (DK) 2015 [10] | 16 | 620 | – | – | 13 | 500 | – | – | 29 | 230 | – | – |
| Foley et al. (IE) 2012 [23] | – | – | 7 | 276 | – | – | 13 | 432 | – | – | – | – |
| Fukushima et al. (JP) 2012 [24] | – | – | – | – | – | – | – | – | – | 1510 | – | |
| Schegerer et al. (DE) 2019 [20] | – | – | – | – | – | – | – | – | 20 | 330 (d) | – | |
| Hausleiter et al. 2009 [25] | – | – | – | – | – | – | – | – | 69,6 | 1152 | – | |
| Japan Network for Research on Medical Exposures (JP) 2015 [26] | – | – | – | – | – | – | – | – | 90 | 1400 | – | – |
| Kanal et al. (USA) 2017 [27] | – | – | – | – | – | – | 19 | 557 | – | – | – | – |
| Mafalanka et al. (FR) 2015 [28] | – | – | – | – | – | – | – | – | – | 870 | – | – |
| Palorini et al. (IT) 2014 [29] | – | – | – | – | – | – | – | – | – | 1208 | – | 131 |
| Public Health England (UK) 2016 [11] | 12 | 610 | 4 | 140 | 12 | 350 | 13 | 440 | – | – | – | – |
| Radiation and Nuclear Safety Authority (FI) 2013 [30] | 11 | 430 | – | – | – | – | – | – | – | – | – | – |
| Salama et al. (EG) 2017 [31] | – | – | – | – | 22 | 421 | – | – | – | – | – | – |
| Schegerer et al. (DE) 2017 [12] | – | – | – | – | – | – | 15 | 300 |
36 (e) 19 (d) |
551 (e) 270 (d) |
8 | 119 |
| Treier et al. (CH) 2010 [21] | – | – | – | – | – | – | – | – | – | 1000 | – | 150 |
| Van der Molen et al. (NL) 2013 [13] | – | – | – | – | – | 276 | – | 371 | – | 671 | – | 51 |
| Wachabauer et al. (AT) 2017 [14] | – | – | – | – | – | – | – | 400 | – | – | – | – |
| Geryes et al. (FR) 2019 [15] | – | – | – | – | – | – | 8 | 310 | – | – | – | – |
| Ireland (IE) MERU 2017 [16] | 7 (a) | 241 (a) | – | – | 7 (a) | 210 (a) | 9 (a) | 234 (a) | – | – | – | – |
| 7 (b) | 272 (b) | – | – | 7 (b) | 249 (b) | 12 (b) | 278 (b) | – | – | – | – | |
| Norway (NO) 2018 [17] | 9 | 350 | – | – | 9 | 300 | – | – | – | – | – | – |
| Sweden (SE) 2019 [18] | 9 | 350 | – | – | – | – | – | – | – | – | – | |
| Public Health England (UK) 2018 [19] | – | – | – | – | – | – | – | – | – | 170 (c) | – | – |
| – | – | – | – | – | – | – | – | – | 280 (d) | – | – | |
| – | – | – | – | – | – | – | – | – | 380 (e) | – | – | |
| Netherlands (NL) 2012 [32] | – | – | – | – | – | – | 10 | 350 | – | – | – | – |
aFor female patients
bFor male patients
cProspective, no padding
dProspective, with padding
eRetrospective, with gating